Internal Medicine, Nephrology · McAllen, TX
NPI
1881693695
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1901 S 1st St
McAllen, TX, 78503
Phone (956) 631-6136
Groups this clinician bills Medicare through
Medicare paid, 2024
$113K
964 services
Medicare patients, 2024
224
Average age 72
Drug cost, 2024
$1.5M
2,953 prescriptions
Company payments, 2025
$2,627
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Salil Mangi was code 90960 (esrd related services (not dialysis)), 205 times for 36 patients. In total Salil Mangi billed 964 services in 19 codes, and Medicare paid $113K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-11-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90960 ESRD Related Services (not dialysis) | Office | 205 | 36 | $285.65 | $59K |
| 99232 Hospital E&M - Subsequent | Facility | 140 | 56 | $62.80 | $8,792 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 99 | 64 | $13.18 | $1,305 |
| 99213 Office E&M - Established | Office | 96 | 75 | $64.04 | $6,148 |
| 99214 Office E&M - Established | Office | 84 | 56 | $83.46 | $7,010 |
| 99233 Hospital E&M - Subsequent | Facility | 59 | 33 | $88.06 | $5,195 |
| 90961 ESRD Related Services (not dialysis) | Office | 37 | 18 | $240.22 | $8,888 |
| 90935 Hemodialysis | Facility | 28 | 17 | $53.77 | $1,505 |
| 99222 Hospital E&M - Initial | Facility | 23 | 23 | $102.50 | $2,357 |
| 99204 Office E&M - New | Office | 15 | 15 | $100.82 | $1,512 |
| 99231 Hospital E&M - Subsequent | Facility | 14 | 12 | $40.22 | $563 |
| 99223 Hospital E&M - Initial | Facility | 12 | 12 | $118.66 | $1,424 |
By year: 2022 $153K for 1,257 services; 2023 $121K for 940 services; 2024 $113K for 964 services.
Medicare prescription drug claims, 2024
In 2024, the drug Salil Mangi prescribed most often to Medicare patients was Amlodipine Besylate, with 192 prescriptions and refills. In total Salil Mangi wrote 2,953 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 192 | 525 | 72 | $1,576 |
| Jardiance Empagliflozin | 166 | 381 | 60 | $211K |
| Farxiga Dapagliflozin Propanediol | 155 | 328 | 45 | $168K |
| Losartan Potassium Generic | 136 | 330 | 47 | $1,486 |
| Metoprolol Succinate Generic | 128 | 351 | 37 | $3,363 |
| Auryxia Ferric Citrate | 124 | 289 | 41 | $388K |
| Nifedipine Er Nifedipine | 118 | 286 | 46 | $4,133 |
| Sevelamer Carbonate Generic | 96 | 216 | 41 | $37K |
| Valsartan Generic | 93 | 263 | 38 | $2,723 |
| Velphoro Sucroferric Oxyhydroxide | 92 | 106 | 23 | $336K |
| Lisinopril Generic | 76 | 208 | 26 | $668 |
| Chlorthalidone Generic | 75 | 204 | 25 | $813 |
| Hydralazine Hcl Generic | 70 | 164 | 27 | $874 |
| Torsemide Generic | 69 | 183 | 25 | $1,319 |
| Veltassa Patiromer Calcium Sorbitex | 64 | 142 | 32 | $131K |
Brand drugs: - claims; generic drugs: 2,182 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Salil Mangi $2,627 ($2,627 in general payments such as food, travel and fees) from 9 companies. The largest payer was Vifor Pharma, Inc. with $2,220.
| Company | Payments | Amount |
|---|---|---|
| Vifor Pharma, Inc. | 3 | $2,220 |
| Calliditas Therapeutics US Inc. | 1 | $115 |
| Mallinckrodt Hospital Products Inc. | 1 | $98.12 |
| Amgen Inc. AMGN | 3 | $56.1 |
| Fresenius USA Marketing, Inc. | 2 | $49.79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36.99 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $17.95 |
| Ardelyx, Inc. ARDX | 1 | $17.47 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $15.05 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.